Clinical Trial Update: Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glucagon-like peptide 2 (GLP-2) in undernourished women with histology-confirmed environmental enteric dysfunction. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Environmental Enteric Dysfunction

Drugs mentioned

• Glucagon-like peptide-2 (glucagon-like peptide-2)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Environmental Enteric Dysfunction | Phase 2 | Status: NOT_YET_RECRUITING